Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens-Reference-Cited by-同舟云学术

Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

Published:2020-01-13 Issue:3 Volume:38 Page:320-332
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Lynn Geoffrey M.^ORCID,Sedlik Christine^ORCID,Baharom Faezzah^ORCID,Zhu Yaling,Ramirez-Valdez Ramiro A.,Coble Vincent L.,Tobin Kennedy,Nichols Sarah R.,Itzkowitz Yaakov,Zaidi Neeha,Gammon Joshua M.,Blobel Nicolas J.,Denizeau Jordan,de la Rochere Philippe,Francica Brian J.,Decker Brennan^ORCID,Maciejewski Mateusz^ORCID,Cheung Justin,Yamane Hidehiro,Smelkinson Margery G.^ORCID,Francica Joseph R.,Laga Richard,Bernstock Joshua D.,Seymour Leonard W.,Drake Charles G.,Jewell Christopher M.,Lantz Olivier,Piaggio Eliane,Ishizuka Andrew S.,Seder Robert A.^ORCID

Funder

Ministerstvo Školství, Mládeže a Tělovýchovy

U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/s41587-019-0390-x.pdf

Reference71 articles.

1. Lennerz, V. et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl Acad. Sci. USA 102, 16013–16018 (2005).